Clinical Trials Directory

Trials / Completed

CompletedNCT00894231

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
AAADRS Clinical Research Center · Academic / Other
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.

Conditions

Interventions

TypeNameDescription
DRUGlevocetirizine (Xyzal)5mg po QD
DRUGplacebosugar tablet

Timeline

Start date
2009-01-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2009-05-06
Last updated
2009-09-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00894231. Inclusion in this directory is not an endorsement.

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis (NCT00894231) · Clinical Trials Directory